Roder J D, Schneider P M, Stein H J, Siewert J R
Chirurgische Klinik und Poliklinik, Technische Universität München, Germany.
Br J Surg. 1995 Dec;82(12):1693-6. doi: 10.1002/bjs.1800821235.
Between 1983 and 1994, 66 patients with cancer of the ampulla of Vater were studied to identify prognostic factors and determine who might benefit from radical resection. Three patients (4.5 per cent) died after operation. Radical resection including lymphadenectomy resulted in potentially curative (R0) resection in 92 per cent. The rate of nodal positivity increased with tumour diameter. Patients with up to two positive lymph nodes had a more favourable prognosis than other patients (P < 0.001). Median survival time for all patients was 41 months; the 5-year survival rate was 35 per cent. Radical resection and lymphadenectomy should therefore be the treatment of choice for patients with tumours of the ampulla of Vater.
1983年至1994年间,对66例 Vater壶腹癌患者进行了研究,以确定预后因素,并确定哪些患者可能从根治性切除术中获益。3例患者(4.5%)术后死亡。包括淋巴结清扫在内的根治性切除术使92%的患者实现了潜在治愈性(R0)切除。淋巴结阳性率随肿瘤直径增加而升高。淋巴结阳性数最多为两个的患者比其他患者预后更好(P<0.001)。所有患者的中位生存时间为41个月;5年生存率为35%。因此,根治性切除和淋巴结清扫术应是 Vater壶腹肿瘤患者的首选治疗方法。